
Whitfield L Knapple MD
Advanced Endoscopic Interventional
Physician
Join to view full profile
3401 Springhill DrSte 400North Little Rock, AR 72117
Phone+1 501-945-3343
Fax+1 501-945-0770
Dr. Knapple is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical University of South CarolinaFellowship, Gastroenterology, 1994 - 1997
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1990 - 1994
University of Arkansas For Medical Sciences College of MedicineClass of 1990
Certifications & Licensure
AR State Medical License 1990 - 2028
SC State Medical License 1994 - 2027
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification gMed Connect, gMed, Inc., 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2014-2017
- CMS Meaningful Use Stage 2 Certification gMed Connect, gMed, Inc., 2014-2017
Clinical Trials
Publications & Presentations
PubMed
- Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Di...Naim Alkhouri, Parvez Mantry, Humberto C Gonzalez, Rashmee Patil, Vicki McIntyre
Journal of Gastrointestinal and Liver Diseases. 2025-12-26 - 15 citationsSafety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bow...Jessica R Allegretti, Paul Feuerstadt, Whitfield L Knapple, Robert Orenstein, Philippe Pinton
Inflammatory Bowel Diseases. 2025-08-01 - 27 citationsPUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent C...Paul Feuerstadt, Teena Chopra, Whitfield Knapple, Nicholas W Van Hise, Erik R Dubberke
Clinical Infectious Diseases. 2025-02-05
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: